Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2025 Aug 8;33(1):e70113. doi: 10.1111/acem.70113

Psychological Comorbidity in Patients Presenting to the Emergency Department With Low‐Risk Chest Pain and Anxiety

Linh Dang 1, Kurt Kroenke 2,✉, Jill Connors 3, Timothy E Stump 4, Patrick O Monahan 4, Yelena Chernyak 5, Emily Holmes 5, Colin Hoffman 4, Kevin Prather 6, Paul I Musey 6
PMCID: PMC12828106  PMID: 40781746

ABSTRACT

Objective

Low‐risk chest pain (LRCP) is one of the most common conditions presenting in the emergency department (ED) and is strongly associated with anxiety. The purpose of this study is to determine the prevalence of other psychological comorbidities and clinical factors associated with severe anxiety in LRCP.

Methods

Baseline data is analyzed from the PACER trial comparing the effectiveness of two telehealth interventions for LRCP patients with anxiety. Key eligibility criteria are a HEART score < 7 and either a GAD‐7 anxiety score ≥ 8 or a positive PHQ screener for panic disorder. Psychological comorbidity measures included the Patient Health Questionnaire 8‐item (PHQ‐8) depression scale, the PHQ‐14 somatization scale, the Primary Care Posttraumatic Stress Disorder Screen, the Sheehan Disability Scale, and the General Self‐Efficacy Scale. Multivariable modeling is used to determine factors associated with severe anxiety.

Results

The 375 patients had a mean age of 39.9; 70.9% were women; 62.9% were White, 32.6% Black, and 4.5% other race. The majority (75%) screened positive for panic disorder, and 42% of participants had severe anxiety (GAD‐7 ≥ 15). Non‐anxiety psychological comorbidity was very high; the proportion of patients exceeding scale cut points was 58% for depression, 57% for PTSD, 52% for somatization, 59% for high disability, and 31% for low self‐efficacy; each was significantly associated with severe anxiety on univariable analysis. Four patient characteristics were independently associated with severe anxiety in multivariable models: odds ratios (95% CI) were 2.7 (1.5–4.9) for depression, 2.3 (1.4–3.9) for low self‐efficacy, 2.1 (1.2–3.6) for low education (high school or less), and 1.8 (1.0 to 3.3) for female sex.

Conclusions

LRCP is accompanied not only by anxiety but also by other potentially treatable psychological comorbidities Severe anxiety is more common in individuals with depression, low self‐efficacy, lower education, and possibly women.

Trail Registration

PACER is registered in clinicaltrials.gov identifier: NCT04811521

Keywords: anxiety, chest pain, depression, emergency medicine, noncardiac, panic

1. Introduction

Chest pain is a major concern of both patients and physicians in the Emergency Department (ED), ranking as the second leading cause for ED visits [1]. A chief complaint of chest pain typically results in a comprehensive work‐up to rule out myocardial infarctions and other serious cardiovascular diseases. However, noncardiac or low‐risk chest pain (LRCP), that is, chest pain that does not pose an imminent risk or have a cardiovascular cause, constitutes the majority (80%) of cases of chest pain presenting to the ED [2, 3, 4]. For these patients, anxiety and panic disorders are two common diagnoses to consider.

Many LRCP patients (up to 40%–60%) without a history of cardiovascular disease will meet criteria for panic disorder (PD) [5, 6, 7, 8, 9, 10]. Even in those who do not have a history of PD and do not meet criteria for PD at the time of their visit, the 6‐month incidence of PD is 10% [11], and the 2‐year incidence is 11% [12]. These numbers are higher than the prevalence of PD in the general population (2.7%) [13] or in primary care (6.8%) [14]. Additionally, generalized anxiety disorder and other anxiety conditions are common in patients presenting with LRCP [7, 8, 10, 11, 12, 15, 16, 17, 18, 19, 20, 21].

Besides of its high prevalence, anxiety is clinically important for several reasons. Anxiety is the 7th leading health‐related cause of years lived with disability and is second only to depression among mental disorders [22]. Additionally, anxiety has substantial adverse effects on multiple domains of health‐related quality of life [23]. Moreover, it frequently co‐occurs with many medical conditions [24]. Importantly, multiple evidence‐based psychotropic, psychotherapeutic, and behavioral treatments are beneficial for anxiety [25, 26, 27]. Therefore, detection and management of anxiety are essential to providing optimal care for patients with LRCP [8].

This paper analyzes baseline data collected in the Patient‐Centered Treatment of Anxiety after Low‐Risk Chest Pain in the Emergency Room (PACER) study in which all participants had at least moderate levels of anxiety symptoms or screened positive for possible panic disorder. The first aim of this secondary analysis was to determine the prevalence of non‐anxiety psychological comorbidities, including depression, somatization, potential posttraumatic stress disorder (PTSD), high disability, and low self‐efficacy. These comorbidities were analyzed because they were assessed at baseline in PACER and have been associated with anxiety in non‐LRCP populations. The second aim was to identify which psychological comorbidities and other patient factors are independently associated with severe anxiety compared to low or moderate levels of anxiety symptoms.

2. Methods

2.1. Study Design and Participation

This study analyzes baseline data from the Patient‐Centered Treatment of Anxiety after Low‐Risk Chest Pain in the Emergency Room (PACER) study, which is described in detail elsewhere [28]. The PACER study is a randomized comparative effectiveness trial with two interventions and one active comparator arm. The sample consists of patients who presented to the Emergency Department (ED) for chest pain, deemed low risk for a major adverse cardiac event, and screened positively for at least a moderate level of anxiety symptoms or potential panic. Most patients underwent screening after completion of the ED physician's evaluation. Enrolled patients were randomized into three treatment arms: (1) referral to primary care with LRCP education; (2) online cognitive‐behavioral therapy (CBT) with guided peer support; or (3) therapist‐led CBT. Treatment effects are measured at 3, 6, 9, and 12 months.

Recruitment for PACER took place in‐person at 6 EDs in the Indiana University Health system by trained research staff or asynchronously via daily report from an electronic health record (EHR) tracking board when research personnel were not present. The target population comprises adult ED patients ≥ 18 years of age with a chief complaint of chest pain who were discharged from the ED or observation unit within 24 h. Low‐risk chest pain was operationalized using an institution‐specific accelerated diagnostic protocol incorporating the Beckman‐Coulter high‐sensitivity troponin I test and the HEART score [28]. HEART scores among enrolled participants were further categorized as low (0–3) and moderate (4–6).

Eligible participants were those who met these inclusion criteria: HEART score < 7 (the acronym standing for history, EKG, age, risk, and troponin) [29]; standard of care diagnostic protocol ruled out possible acute coronary syndrome; and anxiety indicated by a GAD‐7 score ≥ 8 and/or PHQ panic screener score ≥ 2. Patients were excluded if they had any of the following conditions: a new diagnosis of coronary artery disease adjudicated by the physician investigator to be high risk; traumatic chest pain; admission to the hospital; hemodynamic instability; active psychosis, schizophrenia, or suicidal ideation; and barriers to the telecare interventions (e.g., incarceration, homelessness, non‐English speaking). Eligible individuals received a brief intervention (15–30 min) delivered by trained study personnel based on the SBIRT (Screening, Brief Intervention, and Referral for Treatment) model. SBIRT was provided across all 3 arms to briefly educate patients about the link between anxiety and chest pain and motivate them about the potential value of treatment.

This study was approved by the university's Institutional Review Board. Informed consent was obtained prior to participation.

2.2. Measures

2.2.1. Anxiety Measures

Table 1 summarizes the psychological measures administered in PACER. The primary anxiety measure was the 7‐item Generalized Anxiety Disorder‐7 (GAD‐7) scale [30] which is a widely used, evidence‐based measure for the most common anxiety disorders [31]. How much each item/symptom has bothered the individual in the past 2 weeks is scored from 0 to 3, with 0 being “not at all” and 3 being “nearly every day.” Thus, scores range from 0 to 21, with higher scores representing more severe anxiety symptoms. A score ≥ 8 is a validated cutpoint for common anxiety disorders [14]. Scores of 8–14 are considered moderate anxiety, and scores ≥ 15 represent severe anxiety [30]. Some PACER participants had scores < 8 but were eligible if they screened positive on the panic; these were classified as low anxiety. Individuals with GAD‐7 scores ≥ 15 have substantially worse quality of life and functional impairment and higher health care use than those with lower scores [32]. This supported analyzing GAD‐7 as a binary variable to compare participants with severe versus low to moderate anxiety. Moreover, it allowed the use of odds ratios as a metric of risk.

TABLE 1.

Synopsis of psychologic measures in PACER.

Measure Domain No. of items Score range a
Primary
GAD‐7 Anxiety symptom severity 7 0–21
PHQ panic screener Panic symptoms screener 4 0–4
Secondary
PHQ‐8 Depressive symptom severity 8 0–24
PHQ‐14 Somatic symptom severity 14 0–28
PC‐PTSD screener PTSD symptoms screener 4 0–4
Sheehan Disability Scale (SDS) Functional impairment 3 0–30
General Self‐Efficacy Scale (GSES) Self‐efficacy 6 6–24
AUDIT‐C Risky alcohol use 3 0–12

Abbreviations: AUDIT‐C, Alcohol Use Disorders Identification Test consumption questions; GAD, Generalized Anxiety Disorder; PHQ, Patient Health Questionnaire; PTSD‐PC, Primary Care Posttraumatic Stress Disorder Screen.

a

Higher scores are worse for all scales except GSES, for which a lower score is worse.

The PHQ panic disorder module is a 4‐item screener for which a cutpoint of 2 or more items endorsed as “yes” has a 91% sensitivity and 88% specificity for panic disorder [33].

2.2.2. Psychological Comorbidity Measures

The 8‐item Patient Health Questionnaire depression scale (PHQ‐8) measures the frequency of being bothered by depressive symptoms in the past 2 weeks. Each item/symptom is scored from 0 to 3, with 0 being “not at all” and 3 being “nearly every day” [34]. The PHQ‐8 does not include the 9th item of the PHQ‐9 regarding thoughts of self‐harm and is frequently used when depression is a secondary outcome. The PHQ‐8 and PHQ‐9 have identical cutpoints and severity thresholds [35].

The 14‐item Patient Health Questionnaire somatic symptom severity scale (PHQ‐14) was used to assess how much patients have been bothered by common somatic symptoms in the past 4 weeks. Each symptom is scored from 0 to 2, with 0 being “not bothered at all” and 2 being “bothered a lot.” The PHQ‐14 is identical to the PHQ‐15 except for not including the sexual problems item, and the 2 measures have identical severity cutpoints [36, 37].

The Primary Care Posttraumatic Stress Disorder Screen (PC‐PTSD) is a four‐item measure with yes–no response options that assess four dimensions of PTSD (re‐experiencing, numbing, avoidance, and hyperarousal). A cutpoint ≥ 2 was used in our analysis and has a sensitivity from 0.80 to 0.91 and a specificity from 0.72 to 0.84 for PTSD [38, 39].

The Sheehan Disability Scale (SDS) asks patients to what extent their health has interfered with their work, family life, and social life in the past month from 0 (not at all) to 10 (unable to carry on any activities) [40]. A dichotomous threshold for the SDS is not established; because a score of ≥ 5 is considered moderate impairment on each of the 3 subscales, an operational cutpoint of ≥ 15 was used for the full SDS [41, 42, 43].

The General Self‐Efficacy Scale (GSES) has 6 items, with each item scored 1–4 [44]. A dichotomous threshold for the GSES is not established; an operational threshold of < 15 was used for low self‐efficacy based upon both mean item scores in the original study [44], as well as the frequency distribution in our sample (mean = 15.9; median = 16.0).

The AUDIT‐C asks 3 items about alcohol use, with each item scored 0–4. Total scores range from 0 to 12, with unhealthy alcohol use represented by scores ≥ 3 in women and ≥ 4 in men [45].

2.2.3. Additional Data

Medical comorbidity was assessed with a checklist of 9 common medical conditions, including hypertension, diabetes, cardiac disease, pulmonary disease, arthritis, cancer, neurologic disease, liver disease, and renal disease [46]. Sociodemographic data, tobacco use in the past year, frequency of chest pain in the past month, current or past use of medications for anxiety or depression, treatment by a mental health provider, and perceived importance of treatment for anxiety were also captured.

2.3. Statistical Analysis

Descriptive statistics included means (SDs) for continuous variables and proportions for categorical variables. As shown in Table S1, missingness was low, being < 1%–2% for all variables except HEART score (2.9%) and treating anxiety importance (2.1%). The overall sample was divided into three groups according to the GAD‐7 score: low (GAD‐7 < 8), moderate (GAD‐7 of 8–14), and severe (GAD‐7 ≥ 15). Kruskal‐Wallis rank sum test was used to compare continuous variables among groups, and Chi‐squared test or Fisher's exact test (if N for a particular subgroup was small) to compare categorical variables. To determine variables associated with severe anxiety, the latter group was compared to the combined group of low and moderate anxiety. p‐values from univariable comparisons of these 2 groups were not adjusted because the principal purpose was to identify variables significant at p ≤ 0.20 for entry into a multivariable logistic regression model. Results from the model show the independent effect of each variable fully adjusting for other variables in the model. Both unadjusted and adjusted odds ratios (OR) were calculated. Additionally, a least absolute shrinkage and selection operator (LASSO) regression was run as a sensitivity analysis.

The LASSO is a regularization procedure that can shrink model coefficients toward zero, yielding a variable selection technique [47].

3. Results

3.1. Study Sample

Out of 1379 completed eligibility interviews, 476 individuals were positive on both the GAD‐7 and panic screener, 283 on the GAD‐7 only, and 126 on the panic screener only. Of these 865 who met the screening criteria, 375 (43%) were enrolled. These 375 study participants had a mean (SD) age of 39.9 (13.1) with a range from 18 to 74; 70.9% were women; 62.9% were White, 32.6% Black, and 4.5% other (Table S1). The sample ranged considerably in level of education, employment status, income adequacy, and marital status. Most (90.9%) had a low‐risk HEART score, although all were ultimately adjudicated to be low risk through the standard of care accelerated diagnostic protocol. Participants reported a mean of 1.5 medical conditions (from the list of 9 common conditions), with 0, 1, 2, 3, and ≥ 4 conditions reported by 35.5%, 23.2%, 18.4%, 11.5%, and 11.5%, respectively. Chest pain frequency in the past month was no more than once or twice in 36%, once a week in 11%, 2–3 days per week in 29%, and nearly every day in 24%.

3.2. Anxiety Severity and Psychological Comorbidity

Anxiety was moderate with a mean GAD‐7 of 13.1; also, 75% screened positive on the 4‐item panic disorder screener. The number (%) of patients with low, moderate, and severe anxiety was 42 (11.2%), 175 (46.7%), and 158 (42.1%), respectively. Because eligibility required at least moderate anxiety (GAD‐7 ≥ 8) or panic disorder screen positive, 100% of patients with low anxiety (GAD‐7 < 8) screened positive for panic disorder.

Non‐anxiety psychological comorbidity was very high: the proportion of patients exceeding the scale cutpoints was 58% for depression, 57% for PTSD, 52% for somatization, 59% for high disability, and 31% for low self‐efficacy. Moreover, the likelihood of these conditions increased incrementally with the level of anxiety (Figure 1). Additionally, 28% met criteria for risky alcohol use and 19% were current smokers.

FIGURE 1.

FIGURE 1

Prevalence of psychological comorbidity on self‐report scales according to the level of anxiety, with Low = GAD‐7 score < 8; Moderate = GAD‐7 score 8–14; Severe = GAD‐7 score ≥ 15. Depression and PTSD do not represent formal psychiatric diagnoses but instead elevated symptoms (PHQ‐8 score ≥ 10 or PC‐PSTD screener score ≥ 2). Somatization, disability, and low self‐efficacy are defined as PHQ‐14 score ≥ 15, Sheehan Disability Scale score ≥ 15, and General Self‐Efficacy Scale score < 15, respectively.

Most participants had experienced some type of mental health treatment. The majority (71%) reported taking medication for “anxiety, nerves, low mood, or depression” either currently (36%) or in the past (35%). Additionally, 69% reported being “seen or treated by a counselor, psychiatrist, or psychologist” either currently (22%) or in the past (47%). Treatment of anxiety was highly valued, with participants rating the importance of anxiety treatment 8.3 on a scale from 0 (not important at all) to 10 (extremely important).

3.3. Factors Associated With Severe Anxiety

Table 2 compares the low‐moderate anxiety and severe anxiety groups. Patients with severe anxiety were more likely to be female, unmarried, and have less formal education. They also had significantly higher depression, somatization, and disability scores; lower self‐efficacy; and were more likely to screen positive for PTSD, use tobacco, and experience chest pain at least twice a week.

TABLE 2.

Comparison of patients with low–moderate versus severe anxiety.

Characteristic Low‐moderate anxiety (GAD‐7 = 0–14) N = 217 Severe anxiety (GAD‐7 ≥ 15) N = 158 p *
Age, mean (SD) 40.4 (13.6) 39.2 (12.3) 0.613
Sex 0.013
Female 143 (66) 122 (78)
Male 74 (34) 35 (22)
Race 0.598
White 130 (60) 96 (61)
Black 71 (33) 54 (34)
Other 15 (7) 7 (5)
Hispanic or Latino 0.632
No 202 (93) 145 (92)
Yes 15 (7) 13 (8)
Education level < 0.001
High school or less 83 (38) 90 (58)
Technical or some college 72 (33) 43 (28)
4‐year college or postgraduate 62 (29) 22 (14)
Education level – binary < 0.001
More than high school 134 (62) 65 (42)
High school or less 83 (38) 90 (58)
Employment 0.286
Employed 134 (62) 88 (56)
Unemployed 43 (20) 42 (27)
Homemaker, student, or retired 40 (18) 27 (17)
Income adequacy 0.278
Comfortable 71 (33) 45 (29)
Just enough to ends meet 93 (43) 60 (38)
NOT enough to make ends meet 48 (22) 45 (29)
Don't know or refused to answer 5 (2) 7 (5)
Marital status 0.008
Married/partnered 107 (49) 53 (34)
Single 75 (35) 65 (41)
Separated, divorced, or widowed 35 (16) 39 (25)
Marital status – binary 0.003
Married/Partnered 107 (49) 53 (34)
Single, separated, divorced, or widowed 110 (51) 104 (66)
HEART score 0.726
Low (0–3) 191 (91) 140 (90)
Moderate (4–6) 18 (9) 15 (10)
Medical comorbidities, mean (SD) 1.4 (1.5) 1.6 (1.5) 0.085
Medical comorbidities – binary, n (%) 0.102
0–1 135 (62) 85 (54)
≥ 2 82 (38) 73 (46)
GAD‐7 anxiety, mean (SD) 9.7 (3.0) 17.7 (2.1) < 0.001
PHQ Panic screener score, n (%) < 0.001
< 2 71 (33) 22 (14)
≥ 2 146 (67) 136 (86)
PHQ‐8 depression, mean (SD) 9.0 (5.0) 14.4 (5.7) < 0.001
PHQ‐8 depression – binary, n (%) < 0.001
< 10 123 (57) 35 (22)
≥ 10 93 (43) 121 (78)
PHQ‐14 somatization, mean (SD) 13.2 (4.7) 16.3 (4.7) < 0.001
PHQ‐14 somatization – binary, n (%) < 0.001
< 15 128 (59) 50 (32)
≥ 15 89 (41) 106 (68)
PC‐PTSD screener score, n (%) < 0.001
< 2 115 (53) 45 (29)
≥ 2 100 (47) 109 (71)
AUDIT alcohol screener, n (%) 0.848
0–3 in men; 0–2 in women 153 (71) 111 (72)
≥ 4 in men; ≥ 3 in women 62 (29) 43 (28)
Sheehan Disability score, mean (SD) 14.2 (7.4) 18.7 (7.5) < 0.001
Sheehan Disability score – binary, n (%) < 0.001
< 15 111 (51) 41 (26)
≥ 15 105 (49) 114 (74)
General self‐efficacy score, mean (SD) 16.8 (3.1) 14.8 (3.7) < 0.001
General self‐efficacy score – binary, n (%) < 0.001
≥ 15 170 (79) 85 (55)
< 15 45 (21) 69 (45)
Tobacco use in past year, n (%) 0.050
No 139 (65) 84 (55)
Yes 76 (35) 70 (45)
Chest pain frequency in past month, n (%) 0.115
Not at all 6 (3) 5 (3)
Once or twice in the past month 77 (36) 45 (29)
About once a week 29 (13) 13 (8)
2 to 3 days a week 62 (29) 48 (31)
Nearly every day 42 (19) 46 (29)
Chest pain frequency – binary, n (%) 0.025
Not at all/1–2 in past month/once a week 112 (52) 63 (40)
2–3 days a week/nearly every day 104 (48) 94 (60)
Anxiety treatment importance on 0–10 scale, mean (SD) 7.9 (2.6) 8.8 (2.4) < 0.001
Medicines for anxiety/depression ever, n (%) 0.217
No 71 (33) 38 (25)
Yes, in the past but not now 72 (33) 57 (37)
Yes, I am currently taking medication 73 (34) 60 (39)
Treated by mental health provider ever, n (%) 0.860
No 69 (32) 46 (30)
Yes, in the past but not now 100 (46) 76 (49)
Yes, I am currently being seen or treated 47 (22) 33 (21)
*

Means compared using the Kruskal‐Wallis rank sum test. Proportions compared using Pearson's Chi‐squared test. p‐values are not adjusted in this table because the principal purpose of these bivariate comparisons is to select variables with a p ≤ 0.20 for entry into a multivariable model that adjusts for all variables in the model and shows their independent effect.

Table 3 shows odds ratios for variables associated with severe anxiety at a p < 0.20 on univariable (unadjusted) analyses. Of these 11 variables, 3 remained independently associated with severe anxiety after multivariable (adjusted) analyses. Results from multivariable logistic regression revealed ORs (95% CI) for the independent association with severe anxiety of 2.7 (1.5–4.7) for high depression (PHQ‐8 ≥ 10), 2.2 (1.3–3.7) for low educational attainment (high school or less), and 2.0 (1.2–3.4) for low self‐efficacy (GSES < 15). Also, the OR of 1.8 (1.0–3.3) for the association of female sex with severe anxiety was nearly significant. Although not significant, age and race were also included in the models to ensure they were accounted for. Figure 2 illustrates the multivariable rank‐ordered adjusted ORs.

TABLE 3.

Association of patient characteristics with severe anxiety by univariate (unadjusted) and multivariate (adjusted) analyses (n = 364 patients).

Characteristic Unadjusted Adjusted a
OR (95% CI) p OR (95% CI) p
PHQ‐8 depression score
≥ 10 4.57 (2.88, 7.26) < 0.001 2.65 (1.51, 4.70) < 0.001
< 10
Self‐efficacy score
< 15 3.07 (1.94, 4.85) < 0.001 2.04 (1.22, 3.42) 0.006
≥ 15
PHQ‐14 somatization score
≥ 15 3.05 (1.98, 4.70) < 0.001 1.59 (0.92, 2.75) 0.095
< 15
Sheehan disability score
≥ 15 2.94 (1.88, 4.59) < 0.001 1.57 (0.91, 2.72) 0.107
< 15
PC‐PTSD screener score
≥ 2 2.79 (1.78, 4.37) < 0.001 1.44 (0.85, 2.44) 0.169
< 2
Education
High school or less 2.24 (1.47, 3.41) < 0.001 2.16 (1.29, 3.66) 0.004
More than high school
Marital status
Single/separated/divorced/widowed 1.91 (1.25, 2.92) 0.003 1.32 (0.79, 2.21) 0.283
Married/partnered
Sex
Female 1.79 (1.12, 2.86) 0.013 1.76 (1.00, 3.15) 0.053
Male
Chest pain frequency
At least 2–3 days a week 1.61 (1.06, 2.44) 0.025 1.09 (0.67, 1.78) 0.727
Not at all to once week or less
Tobacco use past year
Yes 1.52 (1.00 2.33) 0.050 0.99 (0.59, 1.64) 0.963
No
Medical comorbidities, n
≥ 2 1.41 (0.93, 2.14) 0.102 0.94 (0.54, 1.63) 0.834
0–1
Race b 0.598
Black 0.71 0.42, 1.20 0.207
Other 0.67 0.2 1, 1.97 0.481
White
Age b 0.613 1.00 0.98, 1.02 0.736

Note: Bold p values are for those variables which are significant at p < 0.05.

a

Multivariable logistic regression results for severe anxiety (GAD‐7 score ≥ 15) compared to low‐moderate anxiety (GAD‐7 score 0–14).

b

Unadjusted odds ratios are not calculated for race and age because the variables were not significant at p > 0.20 but were entered into the multivariable model to adjust for demographics.

FIGURE 2.

FIGURE 2

Adjusted odds ratios from multivariable logistic regression for the independent association of patient characteristics with severe anxiety.

Because PHQ‐8 depression had moderately high correlations with PHQ‐14 somatization and Sheehan Disability Scale scores (r = 0.61 and 0.55, respectively), we conducted 2 sensitivity analyses (Table S2). First, we ran the multivariable model without PHQ‐8 depression, which revealed significant adjusted ORs for somatization (2.09, 95% CI 1.25 to 3.50, p = 0.005) and disability (2.11, 95% CI 1.27 to 3.54, p = 0.004). Second, we ran LASSO logistic regression, for which the 3 significant variables from the full multivariable model (depression, low education, low self‐efficacy) remained significant, and the adjusted OR for female sex also proved significant (1.78, 95% CI 1.01 to 3.18, p = 0.047).

4. Discussion

Anxiety is not only very common in patients presenting to the emergency department with low‐risk chest pain but is also associated with substantial non‐anxiety psychological comorbidity and impairment. More than 40% of patients with LRCP who screen positive for anxiety have severe anxiety as determined by a GAD‐7 score of 15 or greater. Severe anxiety, in turn, increases the risk of psychological comorbidity. Factors independently associated with severe anxiety include depression, poor self‐efficacy, lower education, and, in some models, female sex. Our study has a number of strengths, including examining the prevalent and costly problem of LRCP, enrolling a large sample, and administering well‐validated psychological scales. Furthermore, one third of our study participants were Black, in contrast with most prior LRCP studies, which either did not report race or were less racially diverse.

For most patients presenting to the ED with LRCP and anxiety, this represents neither an isolated nor a first episode of chest pain. Indeed, two thirds reported having weekly or even daily episodes of chest pain. Simple reassurance that the chest pain is not cardiac in origin may be insufficient in some of these patients who may have better long‐term outcomes with subsequent outpatient follow‐up and, when indicated, mental health treatments.

It is important to contextualize our findings in light of prior research that has examined the relationship between chest pain and anxiety. Table S3 summarizes 21 previous studies involving 5494 patients, of whom 88% (n = 4829) had non‐cardiac chest pain (NCCP). In addition to NCCP, alternative terms used in these studies include low‐risk chest pain (LRCP) and unexplained chest pain. NCCP has generally been used after a cardiac etiology has been deemed low probability following clinician evaluation augmented by some combination of ECG, cardiac enzymes, and/or noninvasive or invasive cardiologic testing. LRCP is a more recent term that is applied when a risk stratification procedure such as the HEART score [20] or another tool [48] is used to classify patients. Several points warrant highlighting. First, NCCP has been consistently and strongly associated with panic disorder specifically and the severity of anxiety more generally. Second, this association is found regardless of the method used to assess anxiety (e.g., structured psychiatric interviews or self‐report anxiety scales). Third, depression is a common psychological comorbidity. Fourth, these findings are robust across a variety of countries and clinical settings.

Depression was the factor most strongly associated with anxiety in our sample, consistent with the well‐established co‐occurrence of depression and anxiety in previous LRCP studies and many other areas of research [13, 49]. Associated with severe anxiety in univariable analyses, odds ratios for somatization and disability decreased in multivariable modeling but still trended toward significance (p = 0.095 and 0.107, respectively). Further, in the model dropping depression, somatization and disability proved highly significant. The somatization‐anxiety‐depression (SAD) triad has been regularly described, as has the disability and functional impairment associated with each of the 3 component conditions [50, 51].

Female sex was a weak but significant predictor of severe anxiety in our study. In prior LRCP research, female sex has been associated with anxiety in some studies [6, 7, 8, 17] but not in other studies [20, 21, 52, 53]. The broader literature on the relationship between sex and anxiety shows a consistently higher prevalence of anxiety in women [54].

Age was not associated with severe anxiety in our study. Some studies of LRCP have found an association between younger age and anxiety [7, 8, 17, 53, 55] whereas other studies have not [6, 20, 21, 52, 56]. Black patients constituted a third of our sample, and we found that race was not associated with anxiety severity. Most previous studies have either not reported on the racial distribution of their samples or had few minority participants. The few that included racial minorities did not examine the relationship between race and anxiety [10, 20, 55].

Two factors less well‐studied in patients with LRCP include self‐efficacy and substance use. Whereas substance use was not associated with anxiety severity, low self‐efficacy proved significant. It has been shown that self‐efficacy is negatively correlated with anxiety but that changes in self‐efficacy can predict and mediate response to anxiety treatment [57, 58, 59, 60, 61]. Additionally, cognitive‐behavioral therapy and other psychological treatments can increase self‐efficacy [62, 63, 64].

Lower education was associated with anxiety severity in LRCP, which was shown in 1 previous study [55] but not in 3 others [8, 20, 52]. However, large‐scale epidemiological studies indicate that anxiety disorders are more prevalent in individuals with lower education [13, 65]. A large study of 3339 twin pairs found a correlation of −0.30 between educational level and any anxiety disorder and concluded that the relationship was primarily (83% in the best‐fitting models) caused by genes common to educational level and anxiety disorders [66].

In addition to the substantial impairment and psychological comorbidity related to anxiety in patients with LRCP, several other consequences further increase its clinical importance. First, panic disorder and anxiety in general are associated with increased suicidal ideation even after controlling for depression [52, 67]. Second, both anxiety and the concomitant chest pain often persist for months to years after the initial ED visit [12, 68, 69, 70]. Third, only 2%–8% of LRCP patients with anxiety are identified by the ED physician as having an anxiety diagnosis [8, 52, 71]. Fourth, although much of the research on LRCP has focused on panic disorder, our findings and another study [72] reveal a similar importance for generalized anxiety disorders. Fifth, efficient recognition of anxiety is feasible with brief validated screeners [73]. The scales used to assess anxiety and depression severity in PACER are now recognized internationally as core mental health outcome measures [74].

The substantial psychological comorbidity accompanying anxiety has salient treatment implications. Psychological therapies effectively treat anxiety in LRCP [75, 76]. Importantly, however, evidence‐based transdiagnostic treatments can benefit both anxiety and depression [77, 78, 79]. Such treatments can also benefit somatization. A comprehensive review has collated the evidence of an emotional dysfunction superspectrum which includes depression, anxiety, and somatoform spectra [80]. The authors found that dimensions falling within the superspectrum share genetic diatheses, environmental risk factors, cognitive and affective difficulties, neural substrates and biomarkers, childhood temperamental antecedents, and treatment response. A large clinical trial of transdiagnostic cognitive‐behavioral therapy involving 1061 adults with emotional disorders found moderate to large treatment effects for depressive, anxiety, and somatic symptoms, which were sustained at the 12‐month follow‐up [81]. Finally, collaborative care and stepped care models have proven effective for depression, anxiety, and somatic symptoms [82, 83].

4.1. Limitations

Several study limitations should be acknowledged. First, self‐report psychological scales were administered rather than structured psychiatric interviews. Although validated scale cutpoints were used, not all individuals exceeding these cutpoints would meet criteria for a DSM‐V mental disorder. However, those not meeting criteria for a disorder have, at a minimum, elevated psychological symptoms and distress. Second, results regarding PTSD and panic should, in particular, be interpreted cautiously because, unlike the legacy PHQ‐9 and GAD‐7 symptom severity scales, the PTSD and panic measures are 4‐item yes–no measures mainly intended to screen for these 2 disorders rather than calibrate symptom severity or monitor treatment. Third, our inclusion criteria meant that all study participants had some anxiety or panic symptoms. It is likely that LRCP patients without anxiety would have lower non‐anxiety psychological comorbidity. Fourth, the proportion of participants (69%) reporting ever seeing a mental health provider may seem high. However, a single self‐report question was used, a provider was broadly defined as a counselor, psychologist, or psychiatrist, and current use was lower (22%). Moreover, all study participants had elevated anxiety symptoms, which might have prompted higher use than in unselected LRCP patients. Fifth, the fact that all patients had some level of anxiety as an inclusion criterion might have decreased the power of our study to detect an association of certain covariates with anxiety severity in contrast to previous LRCP studies that included both non‐anxious and anxious patients. Sixth, some participation bias is possible given that the enrollment rate among eligible individuals was 43%. Finally, our cross‐sectional analysis means that significant differences represent associations rather than causality.

4.2. Conclusions

Anxiety is not only prevalent in patients presenting to the emergency department with LRCP but is often accompanied by potentially treatable non‐anxiety psychological conditions as well. Of those with anxiety, more than 40% meet the threshold for severe symptoms and may represent a subgroup for whom detection and linkage to outpatient treatment may be especially important.

Author Contributions

Study concept and design: Linh Dang, Kurt Kroenke, Jill Connors, Patrick O. Monahan, Paul I. Musey, and Yelena Chernyak. Acquisition of the data: Colin Hoffman, Kevin Prather, Kurt Kroenke, Jill Connors, Patrick O. Monahan, Paul I. Musey, and Yelena Chernyak. Analysis and interpretation of the data: Linh Dang, Kurt Kroenke, Jill Connors, Patrick O. Monahan, Paul I. Musey, and Colin Hoffman. Drafting of the manuscript: Linh Dang and Kurt Kroenke. Critical revision of the manuscript for important intellectual content: All authors. Statistical expertise: Timothy E. Stump and Patrick O. Monahan. Acquisition of funding. Kurt Kroenke, Jill Connors, Patrick O. Monahan, and Paul I. Musey.

Conflicts of Interest

The authors declare no conflicts of interest.

Supporting information

Data S1.

ACEM-33-0-s001.docx (45KB, docx)

Dang L., Kroenke K., Connors J., et al., “Psychological Comorbidity in Patients Presenting to the Emergency Department With Low‐Risk Chest Pain and Anxiety,” Academic Emergency Medicine 33, no. 1 (2026): e70113, 10.1111/acem.70113.

Funding: This work was supported by Patient‐Centered Outcomes Research Institute (CER2019C3‐17869).

Supervising Editor: Bernard P. Chang

Presentations: This work was presented in part at the Society of Academic Emergency Medicine Annual Meeting, May 14, 2025, Philadelphia, PA.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author.

References

  • 1. Cairns C. and Kang K., National Hospital Ambulatory Medical Care Survey, Emergency Department Summary Tables.
  • 2. Kline J. A., Shapiro N. I., Jones A. E., et al., “Outcomes and Radiation Exposure of Emergency Department Patients With Chest Pain and Shortness of Breath and Ultralow Pretest Probability: A Multicenter Study,” Annals of Emergency Medicine 63, no. 3 (2014): 281–288. [DOI] [PubMed] [Google Scholar]
  • 3. Eslick G. D. and Talley N. J., “Natural History and Predictors of Outcome for Non‐Cardiac Chest Pain: A Prospective 4‐Year Cohort Study,” Neurogastroenterology and Motility 20, no. 9 (2008): 989–997, 10.1111/j.1365-2982.2008.01133.x. [DOI] [PubMed] [Google Scholar]
  • 4. P. I. Musey, Jr. , Bellolio F., Upadhye S., et al., “Guidelines for Reasonable and Appropriate Care in the Emergency Department (GRACE): Recurrent, Low‐Risk Chest Pain in the Emergency Department,” Academic Emergency Medicine 28, no. 7 (2021): 718–744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Beitman B. D., Basha I., Flaker G., et al., “Atypical or Nonanginal Chest Pain. Panic Disorder or Coronary Artery Disease?,” Archives of Internal Medicine 147, no. 9 (1987): 1548–1552. [PubMed] [Google Scholar]
  • 6. Dammen T., Arnesen H., Ekeberg O., and Friis S., “Psychological Factors, Pain Attribution and Medical Morbidity in Chest‐Pain Patients With and Without Coronary Artery Disease,” General Hospital Psychiatry 26, no. 6 (2004): 463–469, 10.1016/j.genhosppsych.2004.08.004. [DOI] [PubMed] [Google Scholar]
  • 7. Demiryoguran N. S., Karcioglu O., Topacoglu H., et al., “Anxiety Disorder in Patients With Non‐Specific Chest Pain in the Emergency Setting,” Emergency Medicine Journal 23, no. 2 (2006): 99–102, 10.1136/emj.2005.025163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Foldes‐Busque G., Marchand A., Chauny J. M., et al., “Unexplained Chest Pain in the ED: Could It Be Panic?,” American Journal of Emergency Medicine 29, no. 7 (2011): 743–751, 10.1016/j.ajem.2010.02.021. [DOI] [PubMed] [Google Scholar]
  • 9. Katon W., Hall M. L., Russo J., et al., “Chest Pain: Relationship of Psychiatric Illness to Coronary Arteriographic Results,” American Journal of Medicine 84, no. 1 (1988): 1–9, 10.1016/0002-9343(88)90001-0. [DOI] [PubMed] [Google Scholar]
  • 10. White K. S., Raffa S. D., Jakle K. R., et al., “Morbidity of DSM‐IV Axis I Disorders in Patients With Noncardiac Chest Pain: Psychiatric Morbidity Linked With Increased Pain and Health Care Utilization,” Journal of Consulting and Clinical Psychology 76, no. 3 (2008): 422–430, 10.1037/0022-006x.76.3.422. [DOI] [PubMed] [Google Scholar]
  • 11. Heppell J. L., Denis I., Turcotte S., Fleet R. P., Dionne C. E., and Foldes‐Busque G., “Incidence of Panic Disorder in Patients With Non‐Cardiac Chest Pain and Panic Attacks,” Journal of Health Psychology 26, no. 7 (2021): 985–994, 10.1177/1359105319859062. [DOI] [PubMed] [Google Scholar]
  • 12. Foldes‐Busque G., de Lafontaine M. F., Turcotte S., and Denis I., “Are Patients at Risk for Developing Panic Disorder After an Emergency Department Visit With Noncardiac Chest Pain?,” Journal of the Academy of Consultation‐Liaison Psychiatry 63, no. 1 (2022): 23–31, 10.1016/j.jaclp.2021.07.011. [DOI] [PubMed] [Google Scholar]
  • 13. Kessler R. C., Chiu W. T., Demler O., Merikangas K. R., and Walters E. E., “Prevalence, Severity, and Comorbidity of 12‐Month DSM‐IV Disorders in the National Comorbidity Survey Replication,” Archives of General Psychiatry 62, no. 6 (2005): 617–627, 10.1001/archpsyc.62.6.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Kroenke K., Spitzer R. L., Williams J. B., Monahan P. O., and Löwe B., “Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection,” Annals of Internal Medicine 146, no. 5 (2007): 317–325, 10.7326/0003-4819-146-5-200703060-00004. [DOI] [PubMed] [Google Scholar]
  • 15. Ho K. Y., Kang J. Y., Yeo B., and Ng W. L., “Non‐Cardiac, Non‐Oesophageal Chest Pain: The Relevance of Psychological Factors,” Gut 43, no. 1 (1998): 105–110, 10.1136/gut.43.1.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Al‐Ani M. and Winchester D. E., “Prevalence and Overlap of Noncardiac Conditions in the Evaluation of Low‐Risk Acute Chest Pain Patients,” Critical Pathways in Cardiology 14, no. 3 (2015): 97–102, 10.1097/hpc.0000000000000050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Cormier L. E., Katon W., Russo J., Hollifield M., Hall M. L., and Vitaliano P. P., “Chest Pain With Negative Cardiac Diagnostic Studies. Relationship to Psychiatric Illness,” Journal of Nervous and Mental Disease 176, no. 6 (1988): 351–358, 10.1097/00005053-198806000-00004. [DOI] [PubMed] [Google Scholar]
  • 18. Goodacre S., Mason S., Arnold J., and Angelini K., “Psychologic Morbidity and Health‐Related Quality of Life of Patients Assessed in a Chest Pain Observation Unit,” Annals of Emergency Medicine 38, no. 4 (2001): 369–376, 10.1067/mem.2001.118010. [DOI] [PubMed] [Google Scholar]
  • 19. Kisely S. R., Creed F. H., and Cotter L., “The Course of Psychiatric Disorder Associated With Non‐Specific Chest Pain,” Journal of Psychosomatic Research 36, no. 4 (1992): 329–335, 10.1016/0022-3999(92)90069-e. [DOI] [PubMed] [Google Scholar]
  • 20. P. I. Musey, Jr. , Patel R., Fry C., Jimenez G., Koene R., and Kline J. A., “Anxiety Associated With Increased Risk for Emergency Department Recidivism in Patients With Low‐Risk Chest Pain,” American Journal of Cardiology 122, no. 7 (2018): 1133–1141, 10.1016/j.amjcard.2018.06.044. [DOI] [PubMed] [Google Scholar]
  • 21. Soares‐Filho G. L., Freire R. C., Biancha K., et al., “Use of the Hospital Anxiety and Depression Scale (HADS) in a Cardiac Emergency Room: Chest Pain Unit,” Clinics (São Paulo, Brazil) 64, no. 3 (2009): 209–214, 10.1590/s1807-59322009000300011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Mokdad A. H., Ballestros K., Echko M., et al., “The State of US Health, 1990‐2016: Burden of Diseases, Injuries, and Risk Factors Among US States,” JAMA 319, no. 14 (2018): 1444–1472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Comer J. S., Blanco C., Hasin D. S., et al., “Health‐Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC),” Journal of Clinical Psychiatry 72, no. 1 (2011): 43–50, 10.4088/JCP.09m05094blu. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Roy‐Byrne P. P., Davidson K. W., Kessler R. C., et al., “Anxiety Disorders and Comorbid Medical Illness,” General Hospital Psychiatry 30, no. 3 (2008): 208–225. [DOI] [PubMed] [Google Scholar]
  • 25. Szuhany K. L. and Simon N. M., “Anxiety Disorders: A Review,” JAMA 328, no. 24 (2022): 2431–2445. [DOI] [PubMed] [Google Scholar]
  • 26. Bandelow B., Reitt M., Röver C., Michaelis S., Görlich Y., and Wedekind D., “Efficacy of Treatments for Anxiety Disorders: A Meta‐Analysis,” International Clinical Psychopharmacology 30, no. 4 (2015): 183–192. [DOI] [PubMed] [Google Scholar]
  • 27. Stonerock G. L., Hoffman B. M., Smith P. J., and Blumenthal J. A., “Exercise as Treatment for Anxiety: Systematic Review and Analysis,” Annals of Behavioral Medicine 49, no. 4 (2015): 542–556. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Connors J. N., Kroenke K., Monahan P., et al., “Comparing the Effectiveness of Existing Anxiety Treatment Options Among Patients Evaluated for Chest Pain and Anxiety in the Emergency Department Setting: Study Protocol for the PACER Pragmatic Randomized Comparative Effectiveness Trial,” Contemporary Clinical Trials 124 (2023): 107020, 10.1016/j.cct.2022.107020. [DOI] [PubMed] [Google Scholar]
  • 29. Backus B. E., Six A. J., Kelder J. C., et al., “A Prospective Validation of the HEART Score for Chest Pain Patients at the Emergency Department,” International Journal of Cardiology 168, no. 3 (2013): 2153–2158, 10.1016/j.ijcard.2013.01.255. [DOI] [PubMed] [Google Scholar]
  • 30. Spitzer R. L., Kroenke K., Williams J. B., and Löwe B., “A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD‐7,” Archives of Internal Medicine 166, no. 10 (2006): 1092–1097, 10.1001/archinte.166.10.1092. [DOI] [PubMed] [Google Scholar]
  • 31. O'Connor E. A., Henninger M. L., Perdue L. A., Coppola E. L., Thomas R. G., and Gaynes B. N., “Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force,” JAMA 329, no. 24 (2023): 2171–2184, 10.1001/jama.2023.6369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Kroenke K., Spitzer R. L., Williams J. B. W., Monahan P. O., and Lowe B., “Anxiety Disorders in Primary Care: Prevalence, Impairment, Comorbidity, and Detection,” Annals of Internal Medicine 146, no. 5 (2007): 317–325. [DOI] [PubMed] [Google Scholar]
  • 33. Löwe B., Gräfe K., Zipfel S., et al., “Detecting Panic Disorder in Medical and Psychosomatic Outpatients: Comparative Validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a Screening Question, and Physicians' Diagnosis,” Journal of Psychosomatic Research 55, no. 6 (2003): 515–519, 10.1016/s0022-3999(03)00072-2. [DOI] [PubMed] [Google Scholar]
  • 34. Kroenke K., Strine T. W., Spitzer R. L., Williams J. B., Berry J. T., and Mokdad A. H., “The PHQ‐8 as a Measure of Current Depression in the General Population,” Journal of Affective Disorders 114, no. 1–3 (2009): 163–173, 10.1016/j.jad.2008.06.026. [DOI] [PubMed] [Google Scholar]
  • 35. Wu Y., Levis B., Riehm K. E., et al., “Equivalency of the Diagnostic Accuracy of the PHQ‐8 and PHQ‐9: A Systematic Review and Individual Participant Data Meta‐Analysis,” Psychological Medicine 50, no. 8 (2020): 1368–1380, 10.1017/s0033291719001314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Zijlema W. L., Stolk R. P., Löwe B., Rief W., White P. D., and Rosmalen J. G., “How to Assess Common Somatic Symptoms in Large‐Scale Studies: A Systematic Review of Questionnaires,” Journal of Psychosomatic Research 74, no. 6 (2013): 459–468, 10.1016/j.jpsychores.2013.03.093. [DOI] [PubMed] [Google Scholar]
  • 37. Toussaint A., Kroenke K., Baye F., and Lourens S., “Comparing the Patient Health Questionnaire ‐ 15 and the Somatic Symptom Scale ‐ 8 as Measures of Somatic Symptom Burden,” Journal of Psychosomatic Research 101 (2017): 44–50, 10.1016/j.jpsychores.2017.08.002. [DOI] [PubMed] [Google Scholar]
  • 38. Prins A., Ouimette P., Kimerling R., et al., “The Primary Care PTSD Screen (PC‐PTSD): Development and Operating Characteristics,” International Journal of Psychiatry in Clinical Practice 9 (2004): 9–14. [Google Scholar]
  • 39. Bliese P. D., Wright K. M., Adler A. B., Cabrera O., Castro C. A., and Hoge C. W., “Validating the Primary Care Posttraumatic Stress Disorder Screen and the Posttraumatic Stress Disorder Checklist With Soldiers Returning From Combat,” Journal of Consulting and Clinical Psychology 76, no. 2 (2008): 272–281, 10.1037/0022-006x.76.2.272. [DOI] [PubMed] [Google Scholar]
  • 40. Leon A. C., Olfson M., Portera L., Farber L., and Sheehan D. V., “Assessing Psychiatric Impairment in Primary Care With the Sheehan Disability Scale,” International Journal of Psychiatry in Medicine 27, no. 2 (1997): 93–105, 10.2190/t8em-c8yh-373n-1uwd. [DOI] [PubMed] [Google Scholar]
  • 41. Sheehan K. H. and Sheehan D. V., “Assessing Treatment Effects in Clinical Trials With the Discan Metric of the Sheehan Disability Scale,” International Clinical Psychopharmacology 23 (2008): 70–83. [DOI] [PubMed] [Google Scholar]
  • 42. Coles T., Coon C., DeMuro C., McLeod L., and Gnanasakthy A., “Psychometric Evaluation of the Sheehan Disability Scale in Adult Patients With Attention‐Deficit/Hyperactivity Disorder,” Neuropsychiatric Disease and Treatment 10 (2014): 887–895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Leon A., Shear M. K., Portera L., and Klerman G., “Assessing Impairment in Patients With Panic Disorder: The Sheehan Disability Scale,” Social Psychiatry and Psychiatric Epidemiology 27 (1992): 78–82. [DOI] [PubMed] [Google Scholar]
  • 44. Romppel M., Herrmann‐Lingen C., and Wachter R., “A Short Form of the General Self‐Efficacy Scale (GSE‐6): Development, Psychometric Properties and Validity in an Intercultural Non‐Clinical Sample and a Sample of Patients at Risk for Heart Failure,” GMS Psycho‐Social‐Medicine 10 (2013): Doc01. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Bush K., Kivlahan D. R., McDonell M. B., Fihn S. D., and Bradley K. A., “The AUDIT Alcohol Consumption Questions (AUDIT‐C): An Effective Brief Screening Test for Problem Drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test,” Archives of Internal Medicine 158, no. 16 (1998): 1789–1795, 10.1001/archinte.158.16.1789. [DOI] [PubMed] [Google Scholar]
  • 46. Perkins A. J., Kroenke K., Unutzer J., et al., “Common Comorbidity Scales Were Similar in Their Ability to Predict Health Care Costs and Mortality,” Journal of Clinical Epidemiology 57, no. 10 (2004): 1040–1048, http://www.ncbi.nlm.nih.gov/pubmed/15528055. [DOI] [PubMed] [Google Scholar]
  • 47. Ranstam J. and Cook J. A., “LASSO Regression,” British Journal of Surgery 105, no. 10 (2018): 1348. [Google Scholar]
  • 48. Foldes‐Busque G., Denis I., Poitras J., Fleet R. P., Archambault P., and Dionne C. E., “A Closer Look at the Relationships Between Panic Attacks, Emergency Department Visits and Non‐Cardiac Chest Pain,” Journal of Health Psychology 24, no. 6 (2019): 717–725, 10.1177/1359105316683785. [DOI] [PubMed] [Google Scholar]
  • 49. Jacobson N. C. and Newman M. G., “Anxiety and Depression as Bidirectional Risk Factors for One Another: A Meta‐Analysis of Longitudinal Studies,” Psychological Bulletin 143, no. 11 (2017): 1155–1200. [DOI] [PubMed] [Google Scholar]
  • 50. Lowe B., Spitzer R. L., Williams J. B., Mussell M., Schellberg D., and Kroenke K., “Depression, Anxiety and Somatization in Primary Care: Syndrome Overlap and Functional Impairment,” General Hospital Psychiatry 30, no. 3 (2008): 191–199, http://www.ncbi.nlm.nih.gov/pubmed/18433651. [DOI] [PubMed] [Google Scholar]
  • 51. Carlehed G., Katz J., and Nordin S., “Somatic Symptoms of Anxiety and Depression: A Population‐Based Study,” Mental Health & Prevention 6 (2017): 57–62. [Google Scholar]
  • 52. Fleet R. P., Dupuis G., Marchand A., Burelle D., Arsenault A., and Beitman B. D., “Panic Disorder in Emergency Department Chest Pain Patients: Prevalence, Comorbidity, Suicidal Ideation, and Physician Recognition,” American Journal of Medicine 101, no. 4 (1996): 371–380, 10.1016/s0002-9343(96)00224-0. [DOI] [PubMed] [Google Scholar]
  • 53. Kuijpers P. M., Denollet J., Wellens H. J., Crijns H. M., and Honig A., “Noncardiac Chest Pain in the Emergency Department: The Role of Cardiac History, Anxiety or Depression and Type D Personality,” European Journal of Cardiovascular Prevention and Rehabilitation 14, no. 2 (2007): 273–279, 10.1097/HJR.0b013e32801da0fc. [DOI] [PubMed] [Google Scholar]
  • 54. Nelson H. D., Cantor A., Pappas M., and Weeks C., “Screening for Anxiety in Adolescent and Adult Women: A Systematic Review for the Women's Preventive Services Initiative,” Annals of Internal Medicine 173, no. 1 (2020): 29–41, 10.7326/M20-0579. [DOI] [PubMed] [Google Scholar]
  • 55. Aikens J. E., Michael E., Levin T., Myers T. C., Lowry E., and McCracken L. M., “Cardiac Exposure History as a Determinant of Symptoms and Emergency Department Utilization in Noncardiac Chest Pain Patients,” Journal of Behavioral Medicine 22, no. 6 (1999): 605–617, 10.1023/a:1018745813664. [DOI] [PubMed] [Google Scholar]
  • 56. Jorm A. F., “Does Old Age Reduce the Risk of Anxiety and Depression? A Review of Epidemiological Studies Across the Adult Life Span,” Psychological Medicine 30, no. 1 (2000): 11–22. [DOI] [PubMed] [Google Scholar]
  • 57. Brown L. A., Wiley J. F., Wolitzky‐Taylor K., et al., “Changes in Self‐Efficacy and Outcome Expectancy as Predictors of Anxiety Outcomes From the CALM Study,” Depression and Anxiety 31, no. 8 (2014): 678–689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Sharma P. K. and Kumra R., “Relationship Between Mindfulness, Depression, Anxiety and Stress: Mediating Role of Self‐Efficacy,” Personality and Individual Differences 186 (2022): 111363. [Google Scholar]
  • 59. Gallagher M. W., Payne L. A., White K. S., et al., “Mechanisms of Change in Cognitive Behavioral Therapy for Panic Disorder: The Unique Effects of Self‐Efficacy and Anxiety Sensitivity,” Behaviour Research and Therapy 51, no. 11 (2013): 767–777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Clarke J., Proudfoot J., and Birch M.‐R., “Effects of Mental Health Self‐Efficacy on Outcomes of a Mobile Phone and Web Intervention for Mild‐To‐Moderate Depression, Anxiety and Stress: Secondary Analysis of a Randomised Controlled Trial,” BMC Psychiatry 14 (2014): 1–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Mousset ES‐P, Lane J., Therriault D., and Roberge P., “Association Between Self‐Efficacy and Anxiety Symptoms in Adolescents: Secondary Analysis of a Preventive Program,” Social and Emotional Learning: Research, Practice, and Policy 3 (2024): 100040. [Google Scholar]
  • 62. Fentz H. N., Arendt M., O'Toole M. S., Hoffart A., and Hougaard E., “The Mediational Role of Panic Self‐Efficacy in Cognitive Behavioral Therapy for Panic Disorder: A Systematic Review and Meta‐Analysis,” Behaviour Research and Therapy 60 (2014): 23–33. [DOI] [PubMed] [Google Scholar]
  • 63. Yang J., Lo W. L. A., Zheng F., Cheng X., Yu Q., and Wang C., “Evaluation of Cognitive Behavioral Therapy on Improving Pain, Fear Avoidance, and Self‐Efficacy in Patients With Chronic Low Back Pain: A Systematic Review and Meta‐Analysis,” Pain Research & Management 2022, no. 1 (2022): 4276175. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Vorensky M., Murray T., McGovern A. F., Patel Y. Y., Rao S., and Batavia M., “Effect of Integrated Exercise Therapy and Psychosocial Interventions on Self‐Efficacy in Patients With Chronic Low Back Pain: A Systematic Review,” Journal of Psychosomatic Research 165 (2023): 111126. [DOI] [PubMed] [Google Scholar]
  • 65. Bijl R. V., Ravelli A., and van Zessen G., “Prevalence of Psychiatric Disorder in the General Population: Results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS),” Social Psychiatry and Psychiatric Epidemiology 33, no. 12 (1998): 587–595, http://www.ncbi.nlm.nih.gov/pubmed/9857791. [DOI] [PubMed] [Google Scholar]
  • 66. Tambs K., Kendler K. S., Reichborn‐Kjennerud T., et al., “Genetic and Environmental Contributions to the Relationship Between Education and Anxiety Disorders–a Twin Study,” Acta Psychiatrica Scandinavica 125, no. 3 (2012): 203–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Foldes‐Busque G., Fleet R., Poitras J., Chauny J. M., Diodati J. G., and Marchand A., “Suicidality and Panic in Emergency Department Patients With Unexplained Chest Pain,” General Hospital Psychiatry 34, no. 2 (2012): 178–184, 10.1016/j.genhosppsych.2011.12.005. [DOI] [PubMed] [Google Scholar]
  • 68. Potts S. G. and Bass C. M., “Psychological Morbidity in Patients With Chest Pain and Normal or Near‐Normal Coronary Arteris: A Long‐Term Follow‐Up Study,” Psychological Medicine 25 (1995): 339–347. [DOI] [PubMed] [Google Scholar]
  • 69. Fleet R. P., Lavoie K. L., Martel J. P., Dupuis G., Marchand A., and Beitman B. D., “Two‐Year Follow‐Up Status of Emergency Department Patients With Chest Pain: Was It Panic Disorder?,” CJEM 5, no. 4 (2003): 247–254, 10.1017/s1481803500008447. [DOI] [PubMed] [Google Scholar]
  • 70. Webster R., Norman P., Goodacre S., Thompson A. R., and McEachan R. R., “Illness Representations, Psychological Distress and Non‐Cardiac Chest Pain in Patients Attending an Emergency Department,” Psychology & Health 29, no. 11 (2014): 1265–1282, 10.1080/08870446.2014.923885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71. Yinclinc K. W., Wulsin L. R., Arnold L. M., and Rouan G. W., “Estimated Prevalences of Panic Disorder and Depression Among Consecutive Patients Seen in an Emergency Department With Acute Chest Pain,” Journal of General Internal Medicine 8 (1993): 231–235. [DOI] [PubMed] [Google Scholar]
  • 72. Hamel S., Denis I., Turcotte S., et al., “Anxiety Disorders in Patients With Noncardiac Chest Pain: Association With Health‐Related Quality of Life and Chest Pain Severity,” Health and Quality of Life Outcomes 20, no. 1 (2022): 7, 10.1186/s12955-021-01912-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Kroenke K., Baye F., and Lourens S. G., “Comparative Validity and Responsiveness of PHQ‐ADS and Other Composite Anxiety‐Depression Measures,” Journal of Affective Disorders 246 (2019): 437–443, 10.1016/j.jad.2018.12.098. [DOI] [PubMed] [Google Scholar]
  • 74. Farber G. K., Gage S., Kemmer D., and White R., “Common Measures in Mental Health: A Joint Initiative by Funders and Journals,” Lancet Psychiatry 10, no. 6 (2023): 465–470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Kisely S. R., Campbell L. A., Yelland M. J., and Paydar A., “Psychological Interventions for Symptomatic Management of Non‐Specific Chest Pain in Patients With Normal Coronary Anatomy,” Cochrane Database of Systematic Reviews 2015, no. 6 (2015), 10.1002/14651858.CD004101.pub5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. van Beek M. H., Oude Voshaar R. C., van Beek A. M., et al., “A Brief Cognitive‐Behavioral Intervention for Treating Depression and Panic Disorder in Patients With Noncardiac Chest Pain: A 24‐Week Randomized Controlled Trial,” Depression and Anxiety 30, no. 7 (2013): 670–678, 10.1002/da.22106. [DOI] [PubMed] [Google Scholar]
  • 77. Cuijpers P., Miguel C., Ciharova M., Ebert D., Harrer M., and Karyotaki E., “Transdiagnostic Treatment of Depression and Anxiety: A Meta‐Analysis,” Psychological Medicine 53, no. 14 (2023): 6535–6546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78. Wegner M., Helmich I., Machado S., Nardi A. E., Arias‐Carrion O., and Budde H., “Effects of Exercise on Anxiety and Depression Disorders: Review of Meta‐Analyses and Neurobiological Mechanisms,” CNS & Neurological Disorders‐Drug Targets 13, no. 6 (2014): 1002–1014. [DOI] [PubMed] [Google Scholar]
  • 79. Cukor J., Xu Z., Vekaria V., et al., “Longitudinal Trajectories of Symptom Change During Antidepressant Treatment Among Managed Care Patients With Depression and Anxiety,” NPJ Mental Health Research 3, no. 1 (2024): 58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Watson D., Levin‐Aspenson H. F., Waszczuk M. A., et al., “Validity and Utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional Dysfunction Superspectrum,” World Psychiatry 21, no. 1 (2022): 26–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Cano‐Vindel A., Muñoz‐Navarro R., Moriana J. A., Ruiz‐Rodríguez P., Medrano L. A., and González‐Blanch C., “Transdiagnostic Group Cognitive Behavioural Therapy for Emotional Disorders in Primary Care: The Results of the PsicAP Randomized Controlled Trial,” Psychological Medicine 52, no. 15 (2022): 3336–3348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Kroenke K., Baye F., Lourens S. G., et al., “Automated Self‐Management (ASM) vs. ASM‐Enhanced Collaborative Care for Chronic Pain and Mood Symptoms: The CAMMPS Randomized Clinical Trial,” Journal of General Internal Medicine 34, no. 9 (2019): 1806–1814, 10.1007/s11606-019-05121-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Kroenke K., Corrigan J. D., Ralston R. K., et al., “Effectiveness of Care Models for Chronic Disease Management: A Scoping Review of Systematic Reviews,” PM & R: The Journal of Injury, Function, and Rehabilitation 16 (2023): 174–189. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data S1.

ACEM-33-0-s001.docx (45KB, docx)

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author.


Articles from Academic Emergency Medicine are provided here courtesy of Wiley

RESOURCES